Search

everythinglearnresearchcommunity

for

Search:↓

High doses of norethindrone acetate in rats caused various organ changes but didn't significantly increase tumor rates.

Gambogic Amide may prevent hair greying and promote hair growth by maintaining hair pigmentation.

MTX and GC combinations are the most effective for early rheumatoid arthritis.

Herbal compounds like ricinoleic acid, quercetin-3-O-rutinoside, and hinokiflavone may be safe and effective for treating hair loss.

Targeted cancer therapies can cause skin side effects, which should be treated early to help patients' quality of life and treatment adherence.

New steroids were effective in blocking male hormone receptors in hamster prostates.

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

Hydroxypinacolone retinoate is a potent anti-aging ingredient for skin that is more effective and less irritating than other forms of retinoids.

Two drugs, finasteride and minoxidil, are approved for hair loss treatment, but new therapies are being developed.

RXR and RAR proteins in skin may help with cell growth, hair growth, and gland function.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

Nitroxide drugs can safely and effectively treat age-related diseases like macular degeneration and cardiovascular issues.

Blocking CRF1 receptors improved male hormone levels and reduced testicular tumor size in men with a specific adrenal condition.

SARMs may be an effective treatment for a certain type of breast cancer by blocking cancer growth and spread.

The document concludes that using gadolinium-based contrast agents during MRI can be linked to Nephrogenic Systemic Fibrosis in patients with severe kidney disease.

GLP-1 agonists may increase the risk of hair loss.

Aromoline and DRD4 are potential targets for osteoarthritis treatment.

Neurosteroids are crucial for stress response, and targeting specific receptors may help treat certain disorders.

Hederagenin shows promise for cancer and inflammation treatment but needs modifications to improve effectiveness.

Neurosteroids can influence behavior by modulating brain inhibition, with potential for treating psychiatric disorders.

New treatments for male hypogonadism are easier to use and target specific tissues to reduce side effects.

Glibenclamide slows breast cancer cell growth by stopping cell division.

Recombinant collagen with nicotinamide boosts hair growth and health.

Potassium channel activators like nicotinamide and minoxidil might help treat solid tumors.

Mutations in the glucocorticoid receptor gene cause reduced sensitivity to glucocorticoids and may lead to poor response to treatment.

New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.

Certain peptides can prevent hair loss in young rats caused by a cancer drug.